Navigation Links
Managing Antibiotic-Resistant Bloodstream Infections with Rapid Molecular Diagnostics educational webinar hosted by Nanosphere and Xtalks
Date:7/18/2013

Northbrook, IL (PRWEB) July 18, 2013

NORTHBROOK, IL—July 18, 2013—Nanosphere, Inc. (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, together with Xtalks, will host an interactive webinar entitled: “Each Hour Counts: Improving Management of Carbapenem-Resistant Enterobacteriaceae (CRE) and Other Antibiotic-Resistant Bloodstream Infections with Rapid Molecular Diagnostics.” The complimentary webinar will be held on Wednesday, August 14, 2013 at 1:00pm EDT.

To register for this event, please visit: http://xtalks.com/eachhourcounts.ashx.

Each year in the United States, there are more than 1.5 million hospital stays associated with bloodstream infections and septicemia, resulting in nearly 100,000 deaths and over $15 billion in healthcare costs [1].

Treatment of these serious bacterial infections in clinical practice is often complicated by antibiotic resistance, which has been associated with prolonged hospital stays, higher health care costs and increased mortality. The recent emergence of CREs is especially troubling, as there are very few antibiotic alternatives available to treat these bacteria.

In this webinar, Karen Carroll, M.D., Professor of Pathology and Medicine at Johns Hopkins University School of Medicine; Nathan Ledeboer, Ph.D., Assistant Professor of Pathology, Medical College of Wisconsin; and Debra Goff, PharmD, Clinical Associate Professor at The Ohio State University College of Pharmacy, will discuss strategies for managing antibiotic-resistant bacterial infections. These recognized leaders will review new molecular technologies that identify bacteria and corresponding antibiotic resistance more rapidly than traditional culture methods, and may enable earlier optimization of antibiotic therapy, thereby improving patient outcomes.

Registrants may qualify to receive a P.A.C.E. continuing education credit for this webinar.

About Xtalks
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

About Nanosphere, Inc.

Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for multiplexed infectious disease, genetic and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere’s product portfolio includes the Verigene Gram-Positive Blood Culture (BC-GP) (510(k) cleared; CE Mark) and Gram-Negative Blood Culture (BC-GN) (RUO; IUO; CE Mark) Tests. Nanosphere is based in Northbrook, IL.

For additional information regarding Nanosphere's infectious disease products, please contact Nanosphere at IDtesting(at)nanosphere(dot)us or visit http://www.nanosphere.us.

Contacts

Investors:
Roger Moody, Chief Financial Officer
Nanosphere, Inc.
+1 847-400-9021
rmoody(at)nanosphere(dot)us

Media:
Lindsey Saxon, Director of Communications
Nanosphere, Inc.
+1 847-400-9173
lsaxon(at)nanosphere(dot)us

Karen Lim, Director of Member Services
Xtalks
+1 416-977-6555 ext 227
clientservices(at)xtalks(dot)com

[1] Elixhauser, A. (Agency for Healthcare Research and Quality), Friedman, B. (Agency for Healthcare Research and Quality) and Stranges, E. (Thomson Reuters). Septicemia in U.S. Hospitals, 2009. HCUP Statistical Brief #122. October 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb122.pdf

Read the full story at http://www.prweb.com/releases/2013/7/prweb10925090.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
2. Effective Strategies for Managing Comparator Product Testing, New Webinar Hosted by Xtalks
3. New Advances and Opportunities in Managing Pain: Translational Animal Models, New Webinar Hosted by Xtalks
4. Trudeau Institute Awarded Grant to Investigate a New Approach to Treating Illnesses Caused by Weaponized and Antibiotic-Resistant Bacteria
5. Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria
6. Highest Genomic Replikin Counts Found in Antibiotic-Resistant Bacteria
7. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
8. New laboratory method uses mass spectrometry to rapidly detect staph infections
9. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
10. SRI International Researchers Developing Bioadhesive Gel to Protect Women from HIV and HSV Infections
11. Ondine Biomedical’s MRSAID(TM) Technology Demonstrates Successful Results in Reducing Surgical Site Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... ... to the scientific and clinical research community’s growing body of knowledge during its ... in the Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, ...
(Date:4/20/2017)... , ... April 20, 2017 , ... Parallel6™ , ... trials worldwide, announced today that they were named one of the 2017 Top ... the latest developments in the pharmaceutical industry. , “We take pride in honoring Parallel6 ...
(Date:4/20/2017)... , April 20, 2017 For ... focuses on novel drug development and clinical research aimed at ... Biostage Inc. (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite ... ZIOP ). You can access our complimentary research reports ... ...
(Date:4/19/2017)... ... 2017 , ... Optofluidics today announced that it's changing its ... changed focus to making analytical tools for biopharmaceutical quality control. “We are excited ... Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson have steered the ...
Breaking Biology Technology:
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
Breaking Biology News(10 mins):